Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth J Pienta

Showing results (291-300 of 519) with videos related to

Pageof 52
Sort By:
Molecular Cell|August 7, 2007
A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growthQianben Wang, Wei Li, X Shirley Liu, et al.
Journal of Cellular Biochemistry|May 23, 2013
Erythropoietin supports the survival of prostate cancer, but not growth and bone metastasisYusuke Shiozawa, Samantha McGee, Michael J Pienta, et al.
Urology|November 14, 2002
A functional thrombin receptor (PAR1) is expressed on bone-derived prostate cancer cell linesChristopher H Chay, Carlton R Cooper, James D Gendernalik, et al.
Analytical Chemistry|September 2, 2025
Liquid Chromatographic and Mass Spectrometric Methods for Quantitative Proteomic Analysis from Single-Cell and Nanogram-Level SamplesYuefan Wang, Jongmin Woo, Zhenyu Sun, et al.
Tomography (Ann Arbor, Mich.)|November 22, 2022
Association of True Positivity with Serum Prostate-Specific Antigen Levels and Other Clinical Factors in Indeterminate PSMA-RADS-3A Lesions Identified on <sup>18</sup>F-DCFPyL PET/CT ScansTushar Garg, Rudolf A Werner, Hyun Woo Chung, et al.
Urology|December 3, 2014
Magnetic resonance-invisible versus magnetic resonance-visible prostate cancer in active surveillance: a preliminary report on disease outcomesSeyed Saeid Dianat, H Ballentine Carter, Kenneth J Pienta, et al.
American Journal of Clinical and Experimental Urology|April 19, 2018
Ten unanswered questions in cancer: "If this is true, what does it imply"?Sarah R Amend, Amber E de Groot, Gonzalo Torga, et al.
Molecular Oncology|April 4, 2017
The prostate metastasis suppressor gene NDRG1 differentially regulates cell motility and invasionAnup Sharma, Janet Mendonca, James Ying, et al.
Clinical Genitourinary Cancer|July 25, 2007
Phase II evaluation of oral estramustine, oral etoposide, and intravenous paclitaxel in patients with hormone-sensitive prostate adenocarcinomaNiklas J Mackler, Kenneth J Pienta, Rodney L Dunn, et al.
The Prostate|November 1, 2014
Beyond immune checkpoint blockade: new approaches to targeting host-tumor interactions in prostate cancer: report from the 2014 Coffey-Holden prostate cancer academy meetingAndrea K Miyahira, Haydn T Kissick, Jennifer L Bishop, et al.
Pageof 52

Showing results (291-300 of 519) with videos related to

Sort By:
Pageof 52
Molecular Cell|August 7, 2007
A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growthQianben Wang, Wei Li, X Shirley Liu, et al.
Journal of Cellular Biochemistry|May 23, 2013
Erythropoietin supports the survival of prostate cancer, but not growth and bone metastasisYusuke Shiozawa, Samantha McGee, Michael J Pienta, et al.
Urology|November 14, 2002
A functional thrombin receptor (PAR1) is expressed on bone-derived prostate cancer cell linesChristopher H Chay, Carlton R Cooper, James D Gendernalik, et al.
Analytical Chemistry|September 2, 2025
Liquid Chromatographic and Mass Spectrometric Methods for Quantitative Proteomic Analysis from Single-Cell and Nanogram-Level SamplesYuefan Wang, Jongmin Woo, Zhenyu Sun, et al.
Tomography (Ann Arbor, Mich.)|November 22, 2022
Association of True Positivity with Serum Prostate-Specific Antigen Levels and Other Clinical Factors in Indeterminate PSMA-RADS-3A Lesions Identified on <sup>18</sup>F-DCFPyL PET/CT ScansTushar Garg, Rudolf A Werner, Hyun Woo Chung, et al.
Urology|December 3, 2014
Magnetic resonance-invisible versus magnetic resonance-visible prostate cancer in active surveillance: a preliminary report on disease outcomesSeyed Saeid Dianat, H Ballentine Carter, Kenneth J Pienta, et al.
American Journal of Clinical and Experimental Urology|April 19, 2018
Ten unanswered questions in cancer: "If this is true, what does it imply"?Sarah R Amend, Amber E de Groot, Gonzalo Torga, et al.
Molecular Oncology|April 4, 2017
The prostate metastasis suppressor gene NDRG1 differentially regulates cell motility and invasionAnup Sharma, Janet Mendonca, James Ying, et al.
Clinical Genitourinary Cancer|July 25, 2007
Phase II evaluation of oral estramustine, oral etoposide, and intravenous paclitaxel in patients with hormone-sensitive prostate adenocarcinomaNiklas J Mackler, Kenneth J Pienta, Rodney L Dunn, et al.
The Prostate|November 1, 2014
Beyond immune checkpoint blockade: new approaches to targeting host-tumor interactions in prostate cancer: report from the 2014 Coffey-Holden prostate cancer academy meetingAndrea K Miyahira, Haydn T Kissick, Jennifer L Bishop, et al.
Pageof 52